EXTENSION OF AN ARTIFICIAL CHROMOSOME-BASED SYSTEM AS A NOVEL DELIVERY STRATEGY FOR CAR-T CELL THERAPY OF OVARIAN CANCER TO HUMAN LYMPHOCYTES

The General Hospital Corporation

Investigators